Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
Developed with scientific support from Austria-based MyBioma, truGut360 brings a comprehensive microbiome analysis solutions available to Indian consumers
LONGENY, a precision-health startup advancing personalised preventive care, has now introduced truGut360 a next-generation gut microbiome test designed to uncover the root biological imbalances fuelling today’s chronic health crisis. Developed with scientific support from Austria-based MyBioma, truGut360 brings one of the most comprehensive microbiome analysis solutions available to Indian consumers.
For years, individuals experiencing persistent bloating, acidity, fatigue, PCOS symptoms, thyroid irregularities, autoimmune issues, weight fluctuations, or unexplained inflammation have had little clarity on underlying causes. truGut360™ changes this by analysing microbial diversity, inflammation markers, metabolic pathways, immune–gut interactions, digestion patterns, and early indicators of long-term disease risk.
truGut360 uses advanced sequencing technology and an AI-driven precision-health framework to deliver personalised, clinically grounded recommendations. It provides insights across multiple areas, including personalised nutrition guidance, digestion and metabolic efficiency, immunity and inflammation reduction, hormonal balance, and overall energy, mood, and long-term vitality. The objective is not just to detect imbalance, but to provide a clear, evidence-backed path to reverse it.
“India is in the middle of a health crisis that most people don’t recognise. Gut dysfunction is driving everything from low energy to hormonal instability to severe metabolic disease, yet it remains invisible in routine check-ups. truGut360 makes the invisible visible. When individuals understand what’s happening inside their gut, they finally get the clarity and direction needed to take control of their health today, not years later,” said Anil KC, Founder and CEO, LONGENY.
“The gut microbiome is a central regulator of long-term health. With truGut360, people across India can now access advanced microbial insights that were once limited to specialised research centres. This represents an important shift toward personalised, proactive health management,” said Dr Nikolaus Gasche, Co-founder & Managing Director, MyBioma